Connect
Connect
with Nuclear & Precision Health Solutions

Thank you for connecting with us.

*
*
*
*
*
 
 
*
Yes, I would like to learn more about Cardinal Health’s products and services by email. I can withdraw my consent or change my preferences by visiting Update Preferences. Visit Privacy Policy for more information about Cardinal Health’s privacy practices.
   
Please fill out this field

FDA-approved radiopharmaceuticals

Industry perspective on FDA-approved radiopharmaceuticals:

Statements from key industry groups that outline recommended guidelines on nuclear pharmacy compounding and the use of FDA-approved radiopharmaceuticals.

Society of Nuclear Medicine

SNM Committee on Pharmacopeia and Commission on Radiopharmaceuticals position statement on compounding and associated risks that should be considered.

National Association of Nuclear Pharmacies

NANP statement on recommended compounding practices for nuclear pharmacists, which stipulates that the compounding of copies of FDA-approved radiopharmaceuticals should be avoided.

Are non-FDA approved drugs used in your hospital?

PDF
119KB – PDF